Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) Shares Outstanding (Weighted Average) (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Shares Outstanding (Weighted Average) for 3 consecutive years, with $16.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed N/A to $16.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.6 million through Dec 2025, changed N/A year-over-year, with the annual reading at $16.6 million for FY2025, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $16.6 million at Adagio Medical Holdings, up from $15.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $16.6 million in Q4 2025, with the low at $1.0 in Q2 2024.
  • Average Shares Outstanding (Weighted Average) over 3 years is $7.3 million, with a median of $987810.0 recorded in 2024.
  • The sharpest move saw Shares Outstanding (Weighted Average) skyrocketed 30.06% in 2024, then soared 1538156400.0% in 2025.
  • Over 3 years, Shares Outstanding (Weighted Average) stood at $759814.0 in 2023, then surged by 30.01% to $987810.0 in 2024, then soared by 1578.17% to $16.6 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $16.6 million, $15.4 million, and $15.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.